News & events
News
Amber Condell likes stories - both hearing them and telling them. That’s why she likes studying genetics.
A study led by researchers at ANU could lead to new treatments for combating drug-resistant malaria, as well as boost existing drugs.
In fiction and popular culture, parasitic characters appear as a metaphor for the threat and spread of disease.
My group focuses on understanding the function of integral membrane transporters and receptors from a structural perspective.
Professor Geoff McFadden has been awarded the Ralph Slatyer Medal for research in understanding the malaria parasite.
Stefan Bröer is looking for the right molecule for a biological target, that could be developed into a drug to treat diabetes. Now ANU has its own library of compounds, available to biological and medical researchers, managed by the Research School of Chemistry.
Events
DNA stability is a prerequisite in many of its applications, ranging from DNA-based vaccine, data storage to gene therapy. However, the existing strategies to enhance the DNA stability are ineffective and limited in scope.
Synthetic chemistry and synthetic biology offer complementary tools for manipulating the 3D architecture and function of biomolecules. I will outline two different projects that exemplify our hybrid chemical biology approach, highlighting divergent applications in catalysis and cancer therapy.
Associate Professor Kelly Roger's team has built a lattice light sheet microscope which was instrumental in the discovery that mitochondrial DNA is released during apoptosis through BAK and BAX pores in the outer mitochondrial membrane.
Malaria is a major global health problem, with 247 million cases and 619,000 deaths estimated in 2021. Antimalarial drugs are critical for malaria treatment and eradication efforts.